Bank of America’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.88M | Buy |
|
|||||
|
2025
Q2 | $4.04M | Buy |
|
|||||
|
2025
Q1 | $925K | Sell |
|
|||||
|
2024
Q4 | $1.03M | Buy |
|
|||||
|
2024
Q3 | $329K | Buy |
|
|||||
|
2024
Q2 | $232K | Sell |
|
|||||
|
2024
Q1 | $650K | Buy |
|
|||||
|
2023
Q4 | $276K | Sell |
|
|||||
|
2023
Q3 | $255K | Buy |
|
|||||
|
2023
Q2 | $93.8K | Sell |
|
|||||
|
2023
Q1 | $108K | Buy |
|
|||||
|
2022
Q4 | $77.2K | Sell |
|
|||||
|
2022
Q3 | $90K | Sell |
|
|||||
|
2022
Q2 | $164K | Buy |
|
|||||
|
2022
Q1 | $290K | Sell |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $456K | Buy |
|
|||||
|
2021
Q2 | $328K | Sell |
|
|||||
|
2021
Q1 | $898K | Buy |
|
|||||
|
2020
Q4 | $208K | Sell |
|
|||||
|
2020
Q3 | $275K | Sell |
|
|||||
|
2020
Q2 | $2M | Sell |
|
|||||
|
2020
Q1 | $1.56M | Buy |
|
|||||
|
2019
Q4 | $964K | Sell |
|
|||||
|
2019
Q3 | $727K | Sell |
|
|||||
|
2019
Q2 | $1.78M | Buy |
|
|||||
|
2019
Q1 | $2.32M | Buy |
|
|||||
|
2018
Q4 | $775K | Sell |
|
|||||
|
2018
Q3 | $1.26M | Sell |
|
|||||
|
2018
Q2 | $3.16M | Buy |
|
|||||
|
2018
Q1 | $2.48M | Buy |
|
|||||
|
2017
Q4 | $2.86M | Sell |
|
|||||
|
2017
Q3 | $6.09M | Buy |
|
|||||
|
2017
Q2 | $4.22M | Sell |
|
|||||
|
2017
Q1 | $3.69M | Sell |
|
|||||
|
2016
Q4 | $5.08M | Sell |
|
|||||
|
2016
Q3 | $4.58M | Sell |
|
|||||
|
2016
Q2 | $4.07M | Sell |
|
|||||
|
2016
Q1 | $9.83M | Buy |
|
|||||
|
2015
Q4 | $8.75M | Buy |
|
|||||
|
2015
Q3 | $3.17M | Buy |
|
|||||
|
2015
Q2 | $1.04M | Buy |
|
|||||
|
2015
Q1 | $211K | Sell |
|
|||||
|
2014
Q4 | $268K | Buy |
|
|||||
|
2014
Q3 | $35K | Buy |
|